Comparison of Intravitreal Ranibizumab and Macular Grid-pattern Laser for Treatment of Diabetic Macular Edema

Sponsor
Szeged University
Study ID
NCT00994799
Status
Unknown

Conditions

  • Macular Edema

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • ranibizumab — DRUG
    10mg/ml intravitreal injection
  • macular grid-pattern laser — RADIATION
    macular grid-pattern laser therapy

Study Details

This study investigates the hypothesis that ranibizumab injection given into the eye is an efficacious and safe treatment option applied for swelling of the macula (site of sharp vision) in diabetes.

Key Dates

First listed
Oct 14, 2009
Start date
Jul 31, 2009
Status verified
Oct 2009
Completion
Feb 28, 2011

Study Design

Enrollment
50 participants (estimated)

Arms

  • Arm: ranibizumab group
    patients receiving intravitreal ranibizumab for diabetic macular edema
  • Arm: laser
    patients receiving macular grid-pattern laser therapy

Primary Outcome Measure

Mean change in best corrected visual acuity [ Time Frame: 12 months ]

Central Contacts

Related Studies